Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Description: The Chemical can be represented with the SMILES CCCC(C(=O)c1ccc(C)cc1)N1CCCC1.Cl.
Answer: Approved
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
CCCC(C(=O)c1ccc(C)cc1)N1CCCC1.Cl
CCCC(C(=O)c1ccc(C)cc1)N1CCCC1.Cl
1-(4-methylphenyl)-2-pyrrolidin-1-ylpentan-1-one;hydrochloride
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.